
Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

